This is the authors' abstract. We don't add key points for this paper.
Objective To examine the role of the preoperative systemic immune-inflammation index (SII) in the success of type 1 tympanoplasty. Methods Between 2016 and 2022, 85 out of 442 patients who underwent type 1 tympanoplasty for chronic otitis media (COM) at our clinic met the inclusion criteria. Demographic data, preoperative complete blood count (CBC) results (including the neutrophil-to-lymphocyte ratio (NLR) and SII), audiological test results, computed tomography findings, and six-month follow-up results were evaluated. Results Anatomic outcomes were categorized into two groups based on graft success: Group 1 (64 patients with successful grafting) and Group 2 (21 patients with graft failure), yielding a success rate of 75.3%. Laboratory findings showed no significant differences in hemoglobin, platelet, or lymphocyte values (p>0.05), but neutrophil count (p < 0.05), NLR, and SII values (p < 0.05) were significantly higher in Group 2. The median SII was 509.1 (422.5-596.7) in Group 1 and 609.9 (521.8-790.5) in Group 2. Conclusions In our study, we found a negative correlation between SII, NLR, and type 1 tympanoplasty success. These parameters might be considered new prognostic inflammatory markers for tympanoplasty outcomes.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Toptaş et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: